[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Medtronic Inc (MDT)

Medtronic Inc (MDT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

What You Need to Know Ahead of Medtronic's Earnings Release

Valued at a market cap of $107.6 billion, Medtronic plc (MDT) develops, manufactures, and sells medical devices and therapies to healthcare systems, physicians, clinicians, and patients. The Galway, Ireland-based company is scheduled to announce its fiscal Q4 earnings for 2026 in the near future. 

Before this event, analysts expect this healthcare company to report a profit of $1.58 per share, down 2.5% from $1.62 per share in the year-ago quarter. The company has topped Wall Street’s bottom-line estimates in each of the last four quarters. Its earnings of $1.36 per share in the previous quarter outpaced the consensus expectations by 2.3%. 

Fundamentals

See More
  • Market Capitalization, $K 107,576,728
  • Shares Outstanding, K 1,283,885
  • Annual Sales, $ 33,537 M
  • Annual Income, $ 4,662 M
  • EBIT $ 7,957 M
  • EBITDA $ 10,818 M
  • 60-Month Beta 0.75
  • Price/Sales 3.19
  • Price/Cash Flow 10.74
  • Price/Book 2.17

Options Overview Details

View History
  • Implied Volatility 25.31% (+1.23%)
  • Historical Volatility 19.24%
  • IV Percentile 87%
  • IV Rank 71.95%
  • IV High 29.67% on 02/13/26
  • IV Low 14.14% on 12/09/25
  • Expected Move (DTE 6) 1.56 (1.88%)
  • Put/Call Vol Ratio 1.39
  • Today's Volume 5,650
  • Volume Avg (30-Day) 7,901
  • Put/Call OI Ratio 0.48
  • Today's Open Interest 135,463
  • Open Int (30-Day) 128,437
  • Expected Range 81.76 to 84.88

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 28 analysts offering recommendations.
Earnings Estimates - Current Qtr 04/30/26
See More
  • Average Estimate $1.58
  • Number of Estimates 10
  • High Estimate $1.69
  • Low Estimate $1.53
  • Prior Year $1.62
  • Growth Rate Est. (year over year) -2.47%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.96 +1.66%
on 04/21/26
89.18 -6.57%
on 03/26/26
-3.26 (-3.77%)
since 03/24/26
3-Month
81.96 +1.66%
on 04/21/26
105.50 -21.02%
on 02/04/26
-17.56 (-17.41%)
since 01/23/26
52-Week
79.93 +4.24%
on 05/23/25
106.33 -21.64%
on 11/26/25
-0.98 (-1.16%)
since 04/24/25

Most Recent Stories

More News
What You Need to Know Ahead of Medtronic's Earnings Release

Medtronic is expected to release its fiscal fourth-quarter earnings soon, and analysts project a single-digit profit drop.

XLV : 144.18 (-1.41%)
$SPX : 7,165.08 (+0.80%)
MDT : 83.32 (-0.56%)
Orchestra BioMed to Present AVIM Therapy Clinical and Mechanistic Data at HRS 2026

Pre-randomization Atrioventricular Interval Modulation Therapy (“AVIM Therapy”)  set-up data from the MODERATO II randomized, prospective, multi-center, double-blind, controlled trial show an ...

MDT : 83.32 (-0.56%)
OBIO : 4.13 (-0.48%)
Intuitive Surgical's Selloff Sets Up a 30% Rebound Opportunity

Intuitive Surgical is the leading robotic surgery stock, outpacing consensus estimates and cementing its first-mover status.

MDT : 83.32 (-0.56%)
ISRG : 482.22 (+0.71%)
Medtronic completes acquisition of CathWorks, expanding its leadership in transforming care for patients with cardiovascular disease

CathWorks   FFRangio®   System employs drug-free, wire-free technology for comprehensive physiological assessment

MDT : 83.32 (-0.56%)
Medtronic to announce financial results for its fourth quarter and full fiscal year 2026

GALWAY, Ireland , April 13, 2026 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results on Wednesday, June 3, 2026,...

MDT : 83.32 (-0.56%)
This Dividend King Is Down 26%. When Will It Bounce Back?

Abbott Laboratories is down 26% from its 52-week high due to a soft quarter. With 54 consecutive years of dividend hikes and guidance calling for mid-single-digit organic sales growth plus 10% EPS expansion,...

ABT : 91.13 (-1.46%)
JNJ : 227.50 (-1.37%)
MDT : 83.32 (-0.56%)
$INX : 7,165.08 (+0.80%)
Medtronic Receives FDA Clearance for Stealth AXiS™ Surgical System for Cranial and ENT Procedures

GALWAY, Ireland , March 27, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth...

MDT : 83.32 (-0.56%)
5 Spin-Off Stocks That Could Reward Patient Investors in 2026

Spin-offs are a way for CEOs to unleash growth and unlock shareholder value; this is a look at five spin-offs that are getting bullish attention from analysts.

LMT : 513.45 (-3.08%)
NOC : 575.11 (-2.14%)
KDP : 29.22 (+2.42%)
HON : 213.17 (-0.55%)
RTX : 174.26 (-2.81%)
KBR : 35.23 (unch)
FDX : 387.98 (-1.20%)
MDT : 83.32 (-0.56%)
ISRG : 482.22 (+0.71%)
Medtronic OmniaSecure™ defibrillation lead is the first lead of its kind to receive FDA approval for conduction system pacing

Built for high reliability, world's only lumenless defibrillation lead approved for placement in the left bundle branch area

MDT : 83.32 (-0.56%)
Is Insulet Stock Underperforming the Dow?

Insulet has underperformed the Dow recently, yet analysts remain highly optimistic about the stock’s prospects.

PODD : 189.56 (-1.38%)
$DOWI : 49,230.71 (-0.16%)
MDT : 83.32 (-0.56%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience...

See More

Key Turning Points

3rd Resistance Point 84.80
2nd Resistance Point 84.28
1st Resistance Point 83.80
Last Price 83.32
1st Support Level 82.81
2nd Support Level 82.29
3rd Support Level 81.81

See More

52-Week High 106.33
Fibonacci 61.8% 96.25
Fibonacci 50% 93.13
Fibonacci 38.2% 90.01
Last Price 83.32
52-Week Low 79.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.